Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients.

scientific article

Haptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients. is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1053124724
P356DOI10.1186/1471-2407-8-389
P932PMC publication ID2627917
P698PubMed publication ID19108738
P5875ResearchGate publication ID23698820

P50authorJos BeijnenQ23771643
Paul N SpanQ57165599
Elisabeth de VriesQ64712784
Jan H M SchellensQ89824209
Harm van TinterenQ92697862
Sjoerd RodenhuisQ116794231
P2093author name stringNathan Harris
Jos W R Twisk
Vivianne C G Tjan-Heijnen
Marijke Bontenbal
Marie-Christine W Gast
Marianne A Nooij
René Q G C M van Hoesel
P2860cites workNucleotide sequence of the haptoglobin and haptoglobin-related gene pair. The haptoglobin-related gene contains a retrovirus-like elementQ24294714
Cancer statistics, 2008Q27860585
Gene expression profiling predicts clinical outcome of breast cancerQ27860732
A gene-expression signature as a predictor of survival in breast cancerQ27860945
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerQ29615523
Class prediction and discovery using gene microarray and proteomics mass spectroscopy data: curses, caveats, cautionsQ30817597
Haptoglobin-alpha subunit as potential serum biomarker in ovarian cancer: identification and characterization using proteomic profiling and mass spectrometry.Q30975693
Haptoglobin alpha-subunit and hepatocyte growth factor can potentially serve as serum tumor biomarkers in small cell lung cancer.Q31063929
HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samplesQ33220604
Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapyQ33224014
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumorsQ33233612
Multicenter validation of a gene expression-based prognostic signature in lymph node-negative primary breast cancer.Q33234978
Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancerQ33288983
Biological functions of haptoglobin--new pieces to an old puzzleQ33368325
Expression of haptoglobin-related protein and its potential role as a tumor antigenQ33837149
Identification of haptoglobin as an angiogenic factor in sera from patients with systemic vasculitisQ33893185
Haptoglobin: function and polymorphism.Q33927500
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancerQ33996115
Meeting highlights: updated international expert consensus on the primary therapy of early breast cancerQ35171086
Angiogenesis and cancer: A cross-talk between basic science and clinical trials (the "do ut des" paradigm).Q36442804
Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutationQ40244200
Biological and clinical significance of haptoglobin polymorphism in humansQ41150251
High-dose chemotherapy with hematopoietic stem-cell rescue for high-risk breast cancer.Q42163493
Haptoglobin polymorphism predicts 30-day mortality and heart failure in patients with diabetes and acute myocardial infarctionQ43622715
Bias as a threat to the validity of cancer molecular-marker researchQ44087175
Haptoglobin polymorphism and mortality in patients with tuberculosis.Q44730475
Haptoglobin polymorphism, iron metabolism and mortality in HIV infectionQ47853455
Haptoglobin polymorphism in patients with preeclampsiaQ49078272
Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study.Q52026600
Lessons from controversy: ovarian cancer screening and serum proteomics.Q52973479
Efficacy of melaleuca oral solution for the treatment of fluconazole refractory oral candidiasis in AIDS patients.Q54131719
Haptoglobin phenotype and diabetic nephropathyQ56990252
Haptoglobin-related protein (Hpr) epitopes in breast cancer as a predictor of recurrence of the diseaseQ69096330
Typing and subtyping of haptoglobin from native serum using disc gel electrophoresis in alkaline buffer: application to routine screeningQ70665067
Discovery-based research and fishingQ73735534
Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative GroupQ77347398
Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patientsQ79986560
P407language of work or nameEnglishQ1860
P304page(s)389
P577publication date2008-12-24
P1433published inBMC CancerQ326300
P1476titleHaptoglobin phenotype is not a predictor of recurrence free survival in high-risk primary breast cancer patients
P478volume8

Reverse relations

cites work (P2860)
Q51113485Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer.
Q47813326Haptoglobin levels, but not Hp1-Hp2 polymorphism, are associated with polycystic ovary syndrome.
Q35866409Identification of genes involved in breast cancer and breast cancer stem cells.
Q33891208Identification of serum protein markers for breast cancer relapse with SELDI-TOF MS.
Q35238008Mass spectrometry-based serum and plasma peptidome profiling for prediction of treatment outcome in patients with solid malignancies
Q35637149Matrix-assisted laser desorption/ionisation (MALDI) TOF analysis identifies serum angiotensin II concentrations as a strong predictor of all-cause and breast cancer (BCa)-specific mortality following breast surgery
Q34018095Postoperative serum proteomic profiles may predict recurrence-free survival in high-risk primary breast cancer
Q34319634Proteomic studies in breast cancer (Review).
Q84779952Serum protein signature may improve detection of ductal carcinoma in situ of the breast

Search more.